Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | ALGS | SNTI | ||
| Company | Catabasis Pharma | Aligos Therapeutics Inc | Senti Biosciences Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.21 | 5.53 | 1.0800 | ||
| High | 9.21 | 5.70 | 1.1100 | ||
| Low | 8.46 | 5.35 | 1.0600 | ||
| Latest | 8.54 | 5.59 | 1.0700 | ||
| Change | -0.64 | +0.14 | +0.0100 | ||
| % Change | -6.97% | +2.57% | +0.94% | ||
| Volume | 98,800 | 90,300 | 112,600 | ||
| 20-Day Average Volume | 395,311 | 77,000 | 174,080 | ||
| Previous Close | 9.18 | 5.45 | 1.0600 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 5.35 | 0.9988 | ||
| 20-Day Raw Stochastic | 56.46% | 69.30% | 68.68% | ||
| 20-Day Relative Strength | 43.24 | 48.72 | 55.46 | ||
| Weighted Alpha | -50.43 | -52.72 | -35.91 | ||
| Today's Opinion | 88% Sell | 88% Sell | 8% Buy | ||
| Previous Opinion | 72% Sell | 88% Sell | 8% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 16% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | +1.64% since 06/25/26 | unch since 06/25/26 | ||
| Low | 8.46 on 09/08/21 | 5.30 on 06/26/26 | 1.0300 on 07/01/26 | ||
| High | 10.26 on 09/02/21 | 5.85 on 07/01/26 | 1.1500 on 06/26/26 | ||
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | +6.48% since 06/02/26 | +8.76% since 06/02/26 | ||
| Low | 6.31 on 08/20/21 | 4.80 on 06/05/26 | 0.8946 on 06/10/26 | ||
| High | 10.26 on 09/02/21 | 5.94 on 06/23/26 | 1.1500 on 06/26/26 | ||
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | -29.86% since 04/02/26 | +24.96% since 04/02/26 | ||
| Low | 6.31 on 08/20/21 | 4.80 on 06/05/26 | 0.8350 on 04/09/26 | ||
| High | 15.72 on 06/16/21 | 8.97 on 04/14/26 | 1.2000 on 04/20/26 | ||
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | -38.77% since 01/02/26 | -2.73% since 01/02/26 | ||
| Low | 6.31 on 08/20/21 | 4.80 on 06/05/26 | 0.7702 on 03/30/26 | ||
| High | 22.01 on 03/18/21 | 10.49 on 01/08/26 | 1.2000 on 04/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 34,590 | 33,325 | ||
| Shares Outstanding, K | 3,904 | 6,188 | 31,145 | ||
| Annual Sales | 0 | 2,190,000 | 20,000 | ||
| Annual Net Income | -37,300,000 | -24,190,000 | -61,440,000 | ||
| Last Quarter Sales | 0 | 2,830,000 | 20,000 | ||
| Last Quarter Net Income | -7,470,000 | -23,040,000 | -4,220,000 | ||
| 60-Month Beta | 1.66 | 2.26 | 2.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -2.21 on 05/07/26 | -0.36 on 05/14/26 | ||
| Earnings Date | 11/11/21 | 08/05/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||